Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mcdorman, K. S.
Right arrow Articles by Wolf, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mcdorman, K. S.
Right arrow Articles by Wolf, D. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens

Kevin S. Mcdorman

Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina, USA

Douglas C. Wolf

National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina, USA, wolf.doug{at}epa.gov

The kidney is a frequent site for chemically induced cancers in rodents and among the 10 most frequent sites for cancer in human patients. Renal cell carcinoma (RCC) is the most frequent upper urinary tract cancer in humans and accounts for 80—85% of malignant renal tumors. Hereditary RCC occurs in Eker rats that are heterozygou s for an insertion mutation in the Tsc2 tumor suppressor gene. The germline mutation renders heterozygous mutants highly susceptible to renal carcinogens. The utility of this model in studying potential renal carcinogens is due to an ordered progression of proliferative renal lesions that can be identified and counted microscopically. The quantitative nature of the model allows for the production of statistically powerful data to understand the relative degree and potency of chemical effects and allow analysis of genetic alterations that may be chemical specific.

Key Words: Eker • renal cell carcinoma • animal model • renal carcinogenesis • Tsc2 • tuberin.

References

  • Huff J., Cirvello J., Haseman J., Bucher J. (1991). Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect 93: 247—270.[Web of Science][Medline] [Order article via Infotrieve]
  • Motzer RJ, Bander NH, Nanus DM (1996). Renal-cell carcinoma. N Engl J Med 335: 865—875.[Free Full Text]
  • National Institutes of Health-National Cancer Institute (2000). Cancer rates and risks; Cancer incidence in the United States (SEER). Available: ( http://seer.cancer.gov/).
  • Hard GC (1986). Experimental models for the sequential analysis of chemically-induced renal carcinogenesis. Toxicol Pathol 14: 112—122.[Abstract/Free Full Text]
  • Tennant RW (1993). Stratification of rodent carcinogenicity bioassay results to refiect relative human hazard. Mutat Res 286: 111—118.[Web of Science][Medline] [Order article via Infotrieve]
  • Ashby J., Tennant RW (1994). Prediction of rodent carcinogenicity for 44 chemicals: Results. Mutagenesis 9: 7—15.[Abstract/Free Full Text]
  • Bjornsson J., Short MP, Kwiatkowski DJ, Henske EP (1996). Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol 149: 1201—1208.[Abstract]
  • Decker HJ, Weidt EJ, Brieger J. (1997). The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Cancer Genet Cytogenet 93: 74—83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gnarra JR, Tory K., Weng Y., Schmidt L., Wei MH, Li H., Latif F., Liu S., Chen F., Duh FM, Lubensky I., Duan DR, Florence C., Pozzatti R., Walther MM, Bander NH, Grossman HB, Brauch H., Pomer S., Brooks JD, Isaacs WB, Lerman MI, Zbar B., Linehan WM (1994). Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85—90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cohen HT (1999). Advances in the molecular basis of renal neoplasia. Curr Opin Nephrol Hypertens 8: 325—331.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fleming S. (1999). Renal cancer genetics: von Hippel Lindau and other syndromes. Int J Dev Biol 43: 469—471.[Web of Science][Medline] [Order article via Infotrieve]
  • Kaelin WG Jr, Maher ER (1998). The VHL tumour-suppressor gene paradigm. Trends Genet 14: 423—426.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • van den Berg A., Buys CH (1997). Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosomes Cancer 19: 59—76.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER (1998). Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 22: 200—209.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Walker C. (1998). Molecular genetics of renal carcinogenesis. Toxicol Pathol 26: 113—120.[Abstract/Free Full Text]
  • Urakami S., Tokuzen R., Tsuda H., Igawa M., Hino O. ( 1997). Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. J Urol 158: 275—278.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Satake N., Urakami S., Hirayama Y., Izumi K., Hino O. ( 1998). Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma. Int J Cancer 77: 895—900.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Toyokuni S., Okada K., Kondo S., Nishioka H., Tanaka T., Nishiyama Y., Hino O., Hiai H. (1998). Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Jpn J Cancer Res 89: 814—820.[CrossRef][Web of Science]
  • Hino O., Fukuda T., Satake N., Kobayashi T., Honda S., Orimoto K., Yamashita Y., Kikuchi Y. (1999). TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer. In: Progress in Experimental Tumor Research: Animal Models of Cancer Predisposition Syndromes, Vol 35, Hiai H, Hino O (eds). Karger, Basel, pp 95—108.
  • Shiao YH, Diwan BA, Perantoni AO, Calvert RJ, Zbar B., Lerman MI, Rice JM ( 1997). Polymerasechainreaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Mol Carcinog 19: 230—235.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kikuchi Y., Kobayashi E., Nishizawa M., Hamazaki S., Okada S., Hino O. ( 1995). Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas. Jpn J Cancer Res 86: 905—909.[CrossRef][Web of Science]
  • Walker C., Ahn YT, Everitt J., Yuan X. ( 1996). Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Mol Carcinog 15: 154—161.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Shiao YH, Rice JM, AndersonLM, Diwan BA, Hard GC ( 1998). von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J Natl Cancer Inst 90: 1720—1723.[Abstract/Free Full Text]
  • Eker R. (1954). Familial renal adenomas in Wistar rats. Acta Pathol Microbiol Scand 34: 554—562.[Medline] [Order article via Infotrieve]
  • Eker R., Mossige J. (1961). A dominant gene for renal adenomas in the rat. Nature 189: 858—859.[Medline] [Order article via Infotrieve]
  • Johannessen JV, Eker R., Sobrinho-Simões M. (1980). The ultrastructure of hereditary renal adenoma s and adenocarcinoma s in rats. JSubmicros c Cytol 12: 463—473.
  • Hino O., Mitani H., Katsuyama H., Kubo Y. ( 1994). A novel cancer predisposition syndrome in the Eker rat model. Cancer Lett 83: 117—121.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hino O., Klein-Szanto AJ, Freed JJ, Testa JR, Brown DQ, Vilensky M., Yeung RS, Tartof KD, Knudson AG (1993). Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci USA 90: 327—331.[Abstract/Free Full Text]
  • Rennebeck G., Kleymenova EV, Anderson R., Yeung RS, Artzt K., Walker CL (1998). Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci USA 95: 15629—15634.[Abstract/Free Full Text]
  • Everitt JI, Goldsworthy TL, Wolf DC, Walker CL (1992). Hereditary renal cell carcinoma in the Eker rat: A rodent familial cancer syndrome. J Urol 148: 1932—1936.[Web of Science][Medline] [Order article via Infotrieve]
  • Eker R., Mossige J., Johannessen JV, Aars H. ( 1981). Hereditary renal adenomas and adenocarcinoma s in rats. Diagn Histopathol 4: 99—110.
  • Everitt JI, Goldsworthy TL, Wolf DC, Walker CL (1995). Hereditary renal cell carcinoma in the Eker rat: A unique animal model for the study of cancer susceptibility. Toxicol Lett 82—83: 621—625.[CrossRef]
  • Walker C., Recio L., Funaki K., Everitt J. (1992). Cytogenetic and molecular correlates between rodent and human renal cell carcinoma. Prog Clin Biol Res 376: 289—302.[Medline] [Order article via Infotrieve]
  • Walker C., Everitt J., Freed JJ, Knudson AG Jr, Whiteley LO (1991). Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma. Cancer Res 51: 2973—2978.[Abstract/Free Full Text]
  • Mydlo JH, Michaeli J., Cordon-Cardo C., Goldenberg AS, Heston WD, Fair WR ( 1989). Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 49: 3407—3411.[Abstract/Free Full Text]
  • Gomella LG, Sargent ER, Wade TP, Anglard P., Linehan WM, Kasid A. (1989). Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. Cancer Res 49: 6972—6975.[Abstract/Free Full Text]
  • Everitt JI, Walker CL, Goldsworthy TW, Wolf DC ( 1997). Altered expression of transforming growth factor-alpha: An early event in renal cell carcinoma development. Mol Carcinog 19: 213—219.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Horesovsky G., Recio L., Everitt J., Goldsworthy T., Wolf DC, Walker C. (1995). p53 status in spontaneous and dimethylnitrosamine-induce d renal cell tumors from rats. Mol Carcinog 12: 236—240.[Web of Science][Medline] [Order article via Infotrieve]
  • Uchida T., Wada C., Shitara T., Egawa S., Mashimo S., Koshiba K. (1993). Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesi s of renal cell carcinoma. J Urol 150: 1298—1301.[Web of Science][Medline] [Order article via Infotrieve]
  • Nanus DM, Mentle IR, Motzer RJ, Bander NH, Albino AP (1990). Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol 143: 175—178.[Web of Science][Medline] [Order article via Infotrieve]
  • Recio L., Lane SC, Ginsler J., Walker C. (1991). Analysis of ras DNA sequences in rat renal cell carcinoma. Mol Carcinog 4: 350—353.[Web of Science][Medline] [Order article via Infotrieve]
  • Yeung RS, Buetow KH, Testa JR, Knudson AG Jr (1993). Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc Natl Acad Sci USA 90: 8038—8042.[Abstract/Free Full Text]
  • Hino O., Mitani H., Nishizawa M., Katsuyama H., Kobayashi E., Hirayama Y. (1993). A novel renal cell carcinoma susceptibility gene maps on chromosome 10 in the Eker rat. Jpn J Cancer Res 84: 1106—1109.[CrossRef][Web of Science]
  • Yeung RS, Xiao GH, Jin F., Lee WC, Testa JR, Knudson AG (1994). Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 91: 11413—11416.[Abstract/Free Full Text]
  • Jin F., Wienecke R., Xiao GH, Maize JC Jr, DeClue JE, Yeung RS (1996). Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci USA 93: 9154—9159.[Abstract/Free Full Text]
  • Kobayashi T., Mitani H., Takahashi R., Hirabayashi M., Ueda M., Tamura H., Hino O. (1997). Transgenic rescue from embryonic lethality and renal carcinogenesi s in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc Natl Acad Sci USA 94: 3990—3993.[Abstract/Free Full Text]
  • Tsuchiya H., Orimoto K., Kobayashi K., Hino O. (1996). Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Cancer Res 56: 429—433.[Abstract/Free Full Text]
  • Kobayashi T., Hirayama Y., Kobayashi E., Kubo Y., Hino O. ( 1995). A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet 9(1): 70—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Soucek T., Yeung RS, Hengstschlager M. (1998). Inactivation of the cyclindependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci USA 95: 15653—15658.[Abstract/Free Full Text]
  • Xiao GH, Shoarinejad F., Jin F., Golemis EA, Yeung RS (1997). The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 272: 6097—6100.[Abstract/Free Full Text]
  • Wienecke R., Konig A., DeClue JE (1995). Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem 270: 16409—16414.[Abstract/Free Full Text]
  • Fukuda T., Kobayashi T., Yasui H., Tsutsumi M., Konishi Y., Hino O. ( 1999). Distribution of Tsc2 protein in various normal rat tissues and renal tumours of Tsc2 mutant (Eker) rat detected by immunohistochemistry. VirchowsArch 434: 341—350.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Al-Saleem T., Wessner LL, Scheithauer BW, Patterson K., Roach ES, Dreyer SJ, Fujikawa K., Bjornsson J., Bernstein J., Henske EP (1998). Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 83: 2208—2216.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Washecka R., Hanna M. (1991). Malignant renal tumors in tuberous sclerosis. Urology 37: 340—343.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • The European Chromosome 16 Tuberous Sclerosis Consortium (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305—1315.[Web of Science][Medline] [Order article via Infotrieve]
  • Carbonara C., Longa L., Grosso E., Mazzucco G., Borrone C., Garre ML, Brisigotti M., Filippi G., Scabar A., Giannotti A., Falzoni P., Monga G., Garini G., Gabrielli M., Riegler P., Danesino C., Ruggieri M., Magro G., Migone N. (1996). Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer 15: 18—25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sepp T., Yates JR, Green AJ (1996). Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 33: 962—964.[Abstract/Free Full Text]
  • Kobayashi T., Minowa O., Kuno J., Mitani H., Hino O., Noda T. (1999). Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res 59: 1206—1211.[Abstract/Free Full Text]
  • Yeung RS, Katsetos CD, Klein-Szanto A. (1997). Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 151: 1477—1486.[Abstract]
  • Funaki K., Everitt J., Oshimura M., Freed JJ, Knudson AG Jr, Walker C. (1991). Hereditary renal cell carcinoma in the rat associatedwithnonrandom loss of chromosomes 5 and 6. Cancer Res 51: 4415—4422.[Abstract/Free Full Text]
  • Walker C., Ginsler J. (1992). Developmen t of a quantitative in vitro transformation assay for kidney epithelial cells. Carcinogenesis 13: 25—32.[Abstract/Free Full Text]
  • Horesovsky G., Ginsler J., Everitt J., Walker C. (1994). Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation. Carcinogenesis 15: 2183—2187.[Abstract/Free Full Text]
  • Dietrich DR, Swenberg JA (1991). Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxi c agents: Predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat Res 248: 239—260.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Walker C., Goldsworthy TL, Wolf DC, Everitt J. (1992). Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science 255: 1693—1695.[Abstract/Free Full Text]
  • Hino O., Mitani H., Knudson AG (1993). Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat. Cancer Res 53: 5856—5858.[Abstract/Free Full Text]
  • Fukuda T., Mitani H., Tsutsumi M., Konishi Y., Hino O. ( 1998). Specific induction of hepatocellular adenomas by transplacental administration of ENU in the tsc2 gene mutant (Eker) rat. Int J Oncol 13: 957—961.[Web of Science][Medline] [Order article via Infotrieve]
  • Wolf DC, Goldsworthy TL, Janszen DB, Harden R., Donner EM, David CS, Everitt JI (2000). Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats. Carcinogenesis 21: 1553—1558.[Abstract/Free Full Text]
  • Wolf DC, Goldsworthy TL, Donner EM, Harden R., Fitzpatrick B., Everitt JI (1998). Estrogen treatment enhances hereditary renal tumor development in Eker rats. Carcinogenesis 19: 2043—2047.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 30, No. 6, 675-680 (2002)
DOI: 10.1080/01926230290168542
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
A. Lanzoni, A. Piaia, J. Everitt, I. Faustinelli, R. Defazio, L. Cavaliere, and P. Cristofori
Early Onset of Spontaneous Renal Preneoplastic and Neoplastic Lesions in Young Conventional Rats in Toxicity Studies
Toxicol Pathol, June 1, 2007; 35(4): 589 - 593.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mcdorman, K. S.
Right arrow Articles by Wolf, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mcdorman, K. S.
Right arrow Articles by Wolf, D. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?